Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
10%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
1
8%
Ph phase_3
6
50%
Ph phase_4
5
42%

Phase Distribution

0

Early Stage

1

Mid Stage

11

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
6(50.0%)
Phase 4Post-market surveillance
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(10)
Terminated(1)
Other(1)

Detailed Status

Completed10
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 36 (50.0%)
Phase 45 (41.7%)

Trials by Status

unknown18%
completed1083%
terminated18%

Recent Activity

0 active trials
Showing 5 of 12
terminatedphase_3

Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation

NCT04655508
completedphase_3

A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma

NCT01202097
completedphase_3

Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.

NCT03468790
completedphase_4

Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma

NCT00829257
completedphase_3

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

NCT01511367
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT04655508Phase 3

Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation

Terminated
NCT01202097Phase 3

A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma

Completed
NCT03468790Phase 3

Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.

Completed
NCT00829257Phase 4

Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma

Completed
NCT01511367Phase 3

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

Completed
NCT03461627Phase 3

Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma

Unknown
NCT00455923Phase 4

SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)

Completed
NCT00642148Phase 2

A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT00901368Phase 4

FACTO Study (Foster® As Complete Treatment Option)

Completed
NCT01274325Phase 3

Comparison of Anti-inflammatory Effects of Seroflo and Seretide in Patients With Asthma

Completed
NCT01647646Phase 4

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

Completed
NCT00262587Phase 4

Elite Sport and Development of Asthma

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12